Lantus is an injectable diabetes medicine that contains insulin glargine, a long-lasting insulin, produced by recombinant DNA technology analogous to human insulin. Antus is indicated in adults and children over 6 years of age for the treatment of diabetes.
Insulin Lantus is produced by Sanofi-Aventis.
- Lantus is indicated for the treatment of type 2 diabetes mellitus in adults and the treatment of type 1 diabetes mellitus in adults and children over 6 years of age who require basal or long-term insulin to control hyperglycemia.
The price of Lantus varies between 84 and 325 reais, depending on the volume of solution of the drug.
Due to the peakless blood sugar reduction profile with a prolonged action of Lantus, the dose is administered subcutaneously once daily; however, it can be administered at any time of the day, at the same time and every day.
Side effects of Lantus include hypoglycaemia, temporary visual disturbances, lipodystrophy and allergic reactions at the injection site.
Lantus is contraindicated in patients with hypersensitivity to insulin glargine or one of the components of the formula, and in children under 6 years of age.